Corneal Findings in Patients Treated With Belantamab Mafodotin
NCT05833737
·
clinicaltrials.gov ↗
TERMINATED
Status
12
Enrollment
OTHER
Sponsor class
Stopped
Study medication market withdrawal by FDA.
Conditions
Multiple Myeloma
Corneal Diseases
Corneal Cyst
Interventions
DRUG:
Belantamab mafodotin
Sponsor
Medical University of Vienna